Limited Competition: Clinical Centers and Data Coordinating Center for the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Trial (U01)
Post Date
September 17th 2009
Application Due Date
November 17th 2009
Funding Opportunity Number
RFA-DK-09-503
CFDA Number(s)
93.213
93.847
Funding Instrument Type(s)
Cooperative Agreement
Funding Activity Categories
Eligibility Categories
State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Funding
-
Estimated Total Funding:
$600000
-
Award Range:
$None - $None
Grant Description
Purpose. The purpose of this limited competition is to continue participant treatment and follow-up by the Clinical Centers (recruiting sites) in the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study. The CAMUS is a randomized placebo-controlled clinical trial of phytotherapy (saw palmetto) in men with lower urinary tract symptoms (LLUTS)/benign prostatic hyperplasia (BPH). A total of 370 men have been randomized into the study and are currently being treated and followed at 11 Clinical Centers. This limited competition will also permit the Data Coordinating Center to continue data collection for the trial, close-out the study in an orderly fashion and to conduct final data analysis. Mechanism of Support. This FOA will utilize the cooperative agreement (U01) grant mechanism. Funds Available and Anticipated Number of Awards. The NIDDK intends to commit approximately $600,000 in FY 2010 to make 12 awards (11 Clinical Centers and 1 Data Coordinating Center award). The NIDDK intends to make a single award of up to $200,000 to the Data Coordinating Center in Fiscal Year 2011.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
-
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-09-503.html
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: